The Price of Two Cancer Drugs Were Raised for the Second Time this Year

Amgen Inc. and Teva Pharmaceutical Industries have raised the price of their cancer drugs (Blincyto and Treanda, respectively) last week for the second time this year. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply